Optic nerve

Global Optic Nerve Diseases Pipeline Study, 2020: Treatment, Products, Drugs, Key Players

Retrieved on: 
Wednesday, February 19, 2020
Visual system, Optic nerve, Optic nerve, Disease, Branches of biology

Optic Nerve Diseases Pipeline Insights, 2020 outlays comprehensive insights of present clinical development scenario and growth prospects across the Optic Nerve Diseases market.

Key Points: 
  • Optic Nerve Diseases Pipeline Insights, 2020 outlays comprehensive insights of present clinical development scenario and growth prospects across the Optic Nerve Diseases market.
  • A detailed picture of the Optic Nerve Diseases pipeline landscape is provided, which includes the disease overview and Optic Nerve Diseases treatment guidelines.
  • The assessment part of the report embraces in-depth Optic Nerve Diseases commercial assessment and clinical assessment of the Optic Nerve Diseases pipeline products from the pre-clinical developmental phase to the marketed phase.
  • Optic Nerve Diseases key players involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.

Nisonic Demonstrates Automatic Measurements of Optic Nerve Sheath Diameter as a Marker for Increased Intracranial Pressure Using Transorbital Ultrasound at Medica In Düsseldorf, Germany

Retrieved on: 
Monday, November 18, 2019
Nervous system, Organ systems, Anatomy, Cranial nerves, Visual system, Optic nerve, Nerve, Non-invasive measurement of intracranial pressure

Nisonic is developing a novel method using properties of the optic nerve sheath to determine the patient's ICP.

Key Points: 
  • Nisonic is developing a novel method using properties of the optic nerve sheath to determine the patient's ICP.
  • Nisonic's method is based on using information about the optic nerve sheath obtained by placing ultrasound transducer on the eyelid.
  • When brain pressure increases, the optic nerve sheath widens and becomes stiffer, and Nisonic combines the optic nerve sheath diameter (ONSD) with additional information gathered from the nerve sheath to estimate the pressure.
  • To enable easy and fast measurements, Nisonic is using Machine Learning methods and has designed a probe optimized for transorbital ultrasound", says Tormod Selbekk (CTO).

Nisonic Demonstrates Automatic Measurements of Optic Nerve Sheath Diameter as a Marker for Increased Intracranial Pressure Using Transorbital Ultrasound at Medica In Düsseldorf, Germany

Retrieved on: 
Monday, November 18, 2019
Nervous system, Organ systems, Anatomy, Cranial nerves, Visual system, Optic nerve, Nerve, Non-invasive measurement of intracranial pressure

Nisonic is developing a novel method using properties of the optic nerve sheath to determine the patient's ICP.

Key Points: 
  • Nisonic is developing a novel method using properties of the optic nerve sheath to determine the patient's ICP.
  • Nisonic's method is based on using information about the optic nerve sheath obtained by placing ultrasound transducer on the eyelid.
  • When brain pressure increases, the optic nerve sheath widens and becomes stiffer, and Nisonic combines the optic nerve sheath diameter (ONSD) with additional information gathered from the nerve sheath to estimate the pressure.
  • To enable easy and fast measurements, Nisonic is using Machine Learning methods and has designed a probe optimized for transorbital ultrasound", says Tormod Selbekk (CTO).

Emerald Bioscience’s NB1111 Demonstrates Superiority in Lowering Intraocular Pressure Compared to Global Standard of Care Glaucoma Treatment in Preclinical Model

Retrieved on: 
Tuesday, October 15, 2019
Senses, Vision, Perception, Visual system, Glaucoma, Blindness, RTT, Optic nerve, Intraocular pressure, Retina, Normal tension glaucoma, Optic neuropathy

These are important experiments prior to initiating multiple human studies, which we project will be conducted throughout 2020.

Key Points: 
  • These are important experiments prior to initiating multiple human studies, which we project will be conducted throughout 2020.
  • Glaucoma is considered one of the optic neuropathies, indicating that there is damage to the cells that comprise the optic nerve.
  • Currently approved therapies are focused on lowering intraocular pressure (IOP) in order to sustain the nerve fibers and prevent a process of programmed cell death or apoptosis.
  • Current therapies focus on lowering intraocular pressure to help preserve retinal ganglion cells that comprise the optic nerve.

2018 Drug Development Pipeline Review for Optic Nerve Disorders (Optic Neuropathy, Glaucoma, LHON and Optic Neuritis)

Retrieved on: 
Friday, November 9, 2018
Nervous system, Peripheral nervous system, Vision, Optic neuropathy, Leber's hereditary optic neuropathy, Optic nerve, Nerve, Optic neuritis, Neuritis, Glaucoma, Mitochondrial optic neuropathies, Optic disc drusen

The "Optic Nerve Disorders Drug Development Pipeline Review, 2018" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Optic Nerve Disorders Drug Development Pipeline Review, 2018" report has been added to ResearchAndMarkets.com's offering.
  • This report provides an overview of the pipeline landscape for disorders of the optic nerve, the bundle of nerve fibers that transmits visual information from the eye to the brain.
  • It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for optic neuropathy, glaucoma, Leber's hereditary optic neuropathy (LHON) and optic neuritis, and features dormant and discontinued products.
  • Molecular targets acted on by products in development for optic nerve disorders include kinases, growth factors and cannabinoid receptors.